Hospi Corporation

Executive Summary

Hospi Corporation is a private medical device company based in San Diego, founded in 2015, that develops patient-centric solutions for home health, hospice, and palliative care. Its flagship product, the Macy Catheter, is an FDA-cleared rectal catheter designed for administering medications and fluids to patients who cannot take oral medications, particularly in end-of-life care. The device addresses common challenges such as dehydration, pain management, and nausea, while reducing the burden on caregivers and healthcare costs. By focusing on comfort and ease of use, Hospi has carved a niche in the underserved palliative care market. The company's innovative approach has the potential to improve quality of life for millions of patients, but it faces competition from traditional IV and subcutaneous routes. Given the growing aging population and increasing emphasis on home-based care, Hospi is well-positioned for growth, though its small size and niche focus limit near-term revenue. The company's long-term success will depend on expanding adoption and securing partnerships within the hospice and home health ecosystems.

Upcoming Catalysts (preview)

• Q3 2026Expansion into hospital and skilled nursing facility markets60% success
• Q4 2026Strategic partnership with a major home health or hospice provider70% success
• Q2 2027FDA clearance for additional indications (e.g., pediatric use or chronic illness)50% success